Dynavax Technologies Corporation Revenue Quarterly YoY Growth:
-11.28% for Dec. 31, 2012Dynavax Technologies Corporation Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -11.28% |
| Dec. 31, 2012 | -84.20% |
| Sept. 30, 2012 | 144.8% |
| June 30, 2012 | -63.08% |
| March 31, 2012 | 34.75% |
| Dec. 31, 2011 | 547.1% |
| Sept. 30, 2011 | -89.92% |
| June 30, 2011 | 231.8% |
| March 31, 2011 | -79.10% |
| Dec. 31, 2010 | -19.32% |
| Sept. 30, 2010 | 301.6% |
| June 30, 2010 | -86.21% |
| March 31, 2010 | -56.87% |
| Dec. 31, 2009 | -81.67% |
| Sept. 30, 2009 | -67.25% |
| June 30, 2009 | 59.19% |
| March 31, 2009 | 206.4% |
| Dec. 31, 2008 | 28.51% |
| Sept. 30, 2008 | 773.5% |
| June 30, 2008 | 454.3% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
DVAX Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Anika Therapeutics | 6.17% |
| MannKind Corporation | |
| Celldex Therapeutics | -0.78% |
DVAX Revenue Quarterly YoY Growth Rankings
| Overall |
46th percentile 4056 of 7590 |
| Sector |
37th percentile 408 of 651 in Healthcare |
| Industry |
59th percentile 97 of 238 in Biotechnology |
DVAX Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -89.92% | Sep 2011 |
| Maximum | 773.5% | Sep 2008 |
| Average | 107.1% |